Privia Health Group, Inc. Operating Lease, Payments
Privia Health Group, Inc. (PRVA) reported Operating Lease, Payments of $2.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-27
- Privia Health Group, Inc. operating lease, payments for the quarter ending 2022-12-31 was $773.00K, a 12.52% increase year-over-year.
- Privia Health Group, Inc. operating lease, payments for the quarter ending 2022-09-30 was $731.00K, a 92.88% increase year-over-year.
- Privia Health Group, Inc. operating lease, payments for the quarter ending 2022-06-30 was $761.00K, a 5.55% increase year-over-year.
- Privia Health Group, Inc. operating lease, payments for the quarter ending 2022-03-31 was $706.00K, a 33.46% increase year-over-year.
- Privia Health Group, Inc. operating lease, payments for fiscal 2025 was $2.37M, a 17.90% decline from fiscal 2024.
- Privia Health Group, Inc. operating lease, payments for fiscal 2024 was $2.89M, a 25.20% decline from fiscal 2023.
- Privia Health Group, Inc. operating lease, payments for fiscal 2023 was $3.86M, a 29.96% increase from fiscal 2022.
- Privia Health Group, Inc. operating lease, payments for fiscal 2022 was $2.97M, a 28.28% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.37M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $2.89M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $3.86M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $773.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.50M derived: sum of 2 quarters · filed 2024-02-27 | $2.27M derived: sum of 3 quarters · filed 2024-02-27 | $2.97M 10-K · filed 2024-02-27 |
| 2022-09-30 | $731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.49M derived: sum of 2 quarters · filed 2022-11-10 | $2.20M 10-Q · filed 2022-11-10 | $2.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | $761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.47M 10-Q · filed 2022-08-11 | $2.15M derived: sum of 3 quarters · filed 2023-03-01 | $2.53M derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | $706.00K 10-Q · filed 2022-05-12 | $1.39M derived: sum of 2 quarters · filed 2023-03-01 | $1.77M derived: sum of 3 quarters · filed 2023-03-01 | $2.49M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.07M derived: sum of 2 quarters · filed 2023-03-01 | $1.79M derived: sum of 3 quarters · filed 2023-03-01 | $2.32M 10-K · filed 2023-03-01 |
| 2021-09-30 | $379.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.10M derived: sum of 2 quarters · filed 2022-11-10 | $1.63M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $721.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.25M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $529.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |